Skip to main
NNOX
NNOX logo

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging Ltd reported a revenue growth of $3.0 million in Q3 2024, marking an increase from $2.5 million in Q3 2023, primarily driven by expansion in its teleradiology services and AI solutions. The company is set to present new clinical data at ECR 2025, further enhancing its positioning in the advanced imaging market, and fulfilling strong demand for high-quality, cost-effective imaging solutions across Europe. Strategic partnerships with significant players such as Fujifilm and SK Telecom bolster its market penetration and distribution capabilities, while collaborations demonstrating superior diagnostic performance highlight the transformative potential of its AI-driven technologies.

Bears say

Nano X Imaging Ltd faces significant challenges that underpin a negative outlook for its stock. The healthcare provider resistance to adopting new technology over established systems, coupled with skepticism regarding the scalability and efficacy of its products, could result in a slower-than-expected uptake and ultimately hinder revenue generation. Furthermore, operational execution issues, regulatory hurdles, and potential future legal challenges may impede the company's ability to commercialize its offerings and negatively impact its financial stability.

Nano-X Imaging (NNOX) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Nano-X Imaging (NNOX) has a Strong Buy consensus rating as of Jul 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $30.10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $30.10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.